drugset / Trial / NCT03136965

Platelet-Rich Plasma Therapy for Patellar Tendinopathy

NCT03136965

RandomizedParallel-groupDouble-blindTreatment

Summary

The overall goal of this research is to find an effective treatment for patellar tendinopathy (PT). To achieve this, we will conduct a double-blinded randomized controlled trial to investigate if platelet-rich plasma is effective for treatment. Clinical (pain and function scores) and bio-mechanical (knee strength) measures will be correlated with disease modification changes assessed using conventional and novel quantitative magnetic resonance imaging (MRI) and ultrasound (US) techniques.

Timeline

Start
2017-04-25
Primary completion
2022-08-15
Completion
2022-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 5 ml Other

Indications